Condition: Prediabetes · Cystic Fibrosis (CF) · Cystic Fibrosis-related Diabetes · Sponsor: Indiana University
The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
This description comes directly from the study's public registry record.
Eslam Montaser, PhD · 4344660570 · emontase@iu.edu
Always discuss trial participation with your own doctor first.
| Indiana University Health, University Hospital | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06642610